We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New AI-Based Method Effectively Identifies Disease Phenotypes Using Light-Based Imaging

By LabMedica International staff writers
Posted on 15 Jul 2025

Precision medicine, where treatment strategies are tailored to a patient's unique disease characteristics, holds great promise for cancer therapy. More...

However, identifying disease phenotypes, which are critical for choosing the most effective treatments, remains a significant challenge. Current methods to identify these phenotypes often require expensive tests, including molecular markers, special stains on tissue samples, or genetic sequencing, which are not always accessible to all patients. This lack of affordable and efficient tools limits the potential benefits of precision medicine for many. Now, researchers have developed a faster and more cost-effective method to identify disease phenotypes in pancreatic cancer.

The new method for disease phenotyping was developed by researchers at the University of Arizona (Tucson, AZ, USA) using label-free optical microscopy and artificial intelligence (AI). The team employed spatial transcriptomics technology to generate spatial maps of gene expression in tissue, helping to understand the disease's behavior. The researchers then used label-free optical microscopy to capture images based on natural fluorescence and second harmonic generation, which is produced by structural proteins like collagen. These images were co-aligned with spatial transcriptomic data to create a comprehensive view of the tissue's phenotype. An AI algorithm, specifically a deep neural network, was trained to predict the tissue's phenotype based solely on these optical images, demonstrating the feasibility of AI-based methods for disease phenotyping.

The new method was able to predict tissue phenotypes with nearly 90% accuracy, marking a significant step forward in applying AI to precision medicine. The research also highlighted that classical image analysis methods were insufficient for predicting phenotypes, underlining the importance of AI-based approaches in linking optical images to disease mechanisms. The findings, published in Biophotonics Discovery, suggest that this method could potentially replace expensive and complex tests with simple light-based imaging and AI analysis. This breakthrough could make precision medicine more accessible and effective in the future. The researchers plan to continue refining this method and explore its broader applications across various types of cancer and other diseases.


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.